Animal model of left atrial thrombus in congestive heart failure in rats.

Related Articles

Animal model of left atrial thrombus in congestive heart failure in rats.

Am J Physiol Heart Circ Physiol. 2019 May 10;:

Authors: Chen J, Strauss B, Liang L, Hajjar RJ

The aim of present study is to develop and study a new model of left atrial thrombus (LAT) in rat of congestive heart failure (CHF).
METHODS: CHF was induced by aortic banding for two months, followed by ischemia/reperfusion (I/R), and subsequently aortic de-banding for one month. Cardiac function and the presence of LAT were assessed by echocardiography. Masson’s staining was performed for histological analysis.
RESULTS: All CHF rats presented with significantly decreased cardiac function, fibrosis in remote myocardium and pulmonary edema. The incidence rate of LAT was 18.8% in the rats. LAT was associated with severity of aortic constriction, aortic pressure gradient, aortic blood flow velocity and pulmonary edema, but not myocardial infarction or degree of left ventricular depression. The progressive process of thrombogenesis was characterized by myocyte hypertrophy, fibrosis and inflammation in the left atrial wall. Fibrin adhesion and clot formation were observed, while most LAT presented as a relatively hard “mass,” likely due to significant fibrosis in the middle and outer layers. Some LAT mass showed focal necrosis as well as fibrin bulging. Most LAT occurred at the upper anterior wall of left atrial appendage. Aortic de-banding had no significant impact on large LATs (> 5 mm2) that had formed, whereas small LATs (< 5 mm2) regressed one month after aortic release.
CONCLUSION: LAT is found in a rat model of aortic banding plus I/R followed by aortic de-banding. The model provides a platform to study molecular mechanisms as well as potential new pathways for LAT treatment.

PMID: 31074653 [PubMed – as supplied by publisher]

Source link

Related posts

Response by Ma et al to Letter Regarding Article, “Novel Mutation in FLNC (Filamin C) Causes Familial Restrictive Cardiomyopathy” [Response to Letter to the Editor]


E-counseling can lower blood pressure, heart disease risk


What causes heart disease part forty-five B – An addendum


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World